Skip to content
DraconiticResearch
Search Sources API
181,686 studies31 sourcesUpdated 2 min ago
Peer-reviewedCC BY 4.0JAMA Network Open

Oral Targeted Therapies and Clinician Comanagement Among Men With Advanced Prostate Cancer

  • Arnav Srivastava1,2
  • Anqi Sun2
  • Megan E. V. Caram3
  • Vahakn B. Shahinian2
  • Brent K. Hollenbeck2
  1. 1Department of Urology, Emory University, Atlanta, Georgia
  2. 2Dow Division of Health Services Research, Department of Urology, University of Michigan, Ann Arbor
  3. 3Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor
Open at sourceDOICite

Abstract

This cross-sectional study examines changes in the prescribing of oral targeted therapy alongside the frequency of comanagement of advanced prostate cancer between urologists and medical oncologists.

Related

  1. Prostate cancer: advancements in targeted therapies
    Ilesha Ewart, Manreet Randhawa
    Frontiers in endocrinologyPeer-reviewedCC BYFull textEndocrinology & metabolismEurope PMCCrossref
  2. Commentary: Selpercatinib versus multi-kinase inhibitors for advanced medullary thyroid cancer: a network meta-analysis of RET-targeted therapies.
    Arnau Domenech, Martí Hopmans, Erin Barker +2
    Frontiers in endocrinologyPeer-reviewedCC BYFull textEndocrinology & metabolismEurope PMCCrossref
  3. Combined Use of Clinician Prediction of Survival and the Palliative Prognostic Index for Short‐Term Mortality Screening in Advanced Cancer Patients in an Acute Care Hospital
    Tomoko Shiraishi, Megumi Kimura, Naomi Nabeshima +5
    Cancer reports (Hoboken, N.J.)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Clinician Perspectives on Automated Facial Analysis for Pain Assessment: A Cross-Sectional Survey of Physicians, Advanced Practice Providers, and Nurses
    C. S. Mullins, C. Espelien, M. Gurka +1
    medRxivPreprintCC BY-NCFull textSurgery & anaesthesiamedRxiv
  5. Hippo pathway in cancer ferroptosis: from mechanism insights to targeted therapies
    Ziyi Xu, Ruochen Yang, Hudabia Akram +1
    Frontiers in medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@article{srivastava2026oral,
  title = {{Oral Targeted Therapies and Clinician Comanagement Among Men With Advanced Prostate Cancer}},
  author = {Arnav Srivastava and Anqi Sun and Megan E. V. Caram and Vahakn B. Shahinian and Brent K. Hollenbeck},
  journal = {JAMA Network Open},
  year = {2026},
  month = oct,
  doi = {10.1001/jamanetworkopen.2026.39853},
  url = {https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2855577},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Oral Targeted Therapies and Clinician Comanagement Among Men With Advanced Prostate Cancer
AU  - Arnav Srivastava
AU  - Anqi Sun
AU  - Megan E. V. Caram
AU  - Vahakn B. Shahinian
AU  - Brent K. Hollenbeck
PY  - 2026
DA  - 2026/10/21
JO  - JAMA Network Open
DO  - 10.1001/jamanetworkopen.2026.39853
UR  - https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2855577
AB  - This cross-sectional study examines changes in the prescribing of oral targeted therapy alongside the frequency of comanagement of advanced prostate cancer between urologists and medical oncologists.
SN  - 2574-3805
ER  -